---
title: "RECBIO's new drug application for REC610 has been accepted"
description: "RECBIO-B announced that the new drug application for its new adjuvanted recombinant herpes zoster vaccine REC610 has been officially accepted by the Center for Drug Evaluation of the National Medical "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/271018321.md"
published_at: "2025-12-29T16:47:55.000Z"
---

# RECBIO's new drug application for REC610 has been accepted

> RECBIO-B announced that the new drug application for its new adjuvanted recombinant herpes zoster vaccine REC610 has been officially accepted by the Center for Drug Evaluation of the National Medical Products Administration. Currently, the only new adjuvanted recombinant herpes zoster vaccine available globally is GlaxoSmithKline's Shingrix

RECBIO-B (02179.HK) announced that the new drug application for its adjuvanted recombinant herpes zoster vaccine REC610 has been officially accepted by the Center for Drug Evaluation of the National Medical Products Administration. Currently, the only adjuvanted recombinant herpes zoster vaccine available globally is GlaxoSmithKline's Shingrix

### Related Stocks

- [02179.HK - RECBIO-B](https://longbridge.com/en/quote/02179.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 中金公司重申对苏州瑞博生物科技有限公司 H 股（6938）的买入评级 | 在昨天发布的一份报告中，中金公司对苏州瑞博生物科技有限公司 H 股维持了买入评级，目标价为 100.00 港元。总统日促销 - 70% 折扣解锁对冲基金级别的数据和强大的投资工具，以便做出更聪明、更精准的决策。通过最新的新闻和分析，保持市场 | [Link](https://longbridge.com/en/news/276199846.md) |
| 大人国际称其子公司将以 3140 万港元出售 Lordan Group 的 20,000 股普通股 | 大人国际有限公司：单位以 3140 万港元出售 Lordan Group 的 20,000 股普通股 | [Link](https://longbridge.com/en/news/276043299.md) |
| 参观一个 3000 吨容量的筒仓扩建项目 | 查看 Rockscape Farm 巨大的新筒仓容量，以及它如何在收获季节提升储存和效率 | [Link](https://longbridge.com/en/news/276076561.md) |
| RKF Jr.执政一年：他的 MAHA 议程如何改变美国公共卫生 | 卫生与公共服务部部长罗伯特·F·肯尼迪（Robert F. Kennedy Jr.）已完成其任期的第一年，实施了 “让美国再次健康”（Make America Healthy Again，MAHA）议程下的重要变革。他的任期遭到了医学协会和 | [Link](https://longbridge.com/en/news/275944745.md) |
| 深海鱼类凭借新颖的视觉系统打破常规 | 新的研究发现了一种深海鱼类的新型视觉细胞，结合了杆细胞和锥细胞的特征，适应低光照条件。这种混合光感受器在三种鱼类的幼虫中被发现：刀鱼、光鱼和灯笼鱼，其中刀鱼在成年后仍保留这些细胞。该研究挑战了传统的固定杆细胞和锥细胞类型的观点，暗示了更灵活 | [Link](https://longbridge.com/en/news/276218702.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.